Eton Pharmaceuticals Competitors and Similar CompaniesClear all

Eton Pharmaceuticals's competitors and similar companies include UCB, Genentech and Mankind Pharma.

	Eton Pharmaceuticals Eton Pharmaceuticals, a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
Founding Date	Founding Date 2017	Founding Date 1928	Founding Date 1976	Founding Date 1995
Type	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Palatine, US HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations New Delhi, IN HQ
Employees	Employees 15	Employees 9,052	Employees 18,077	Employees 16,2532% increase
Valuation ($)	Valuation ($) 220.6 m	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $80m (FY, 2025)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $37.2m (FY, 2025)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $42.7m (FY, 2025)	Gross profit €7.2b (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income ($4.6m) (FY, 2025)	Net income €1.6b (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 20m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 239m